Know Cancer

or
forgot password

Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities


Phase 4
18 Years
85 Years
Not Enrolling
Female
Cervical Cancer

Thank you

Trial Information

Dissemination of Cervical Cancer Screening to Primary Care Physicians in Underserved Communities


The specific aims of this proposal are:

1. To test the hypothesis that an intervention, multi-component academic detailing, will
increase the rate of physician cervical cancer screening at 3- and 6-months
post-randomization, compared to the rate observed in a service-as-usual control.

2. To develop models predicting which physician offices are most and least likely to adopt
the intervention, and to generate hypotheses about tailoring the dissemination of
cervical cancer screening guidelines to different physician subgroups.

3. To conduct a cost-effectiveness analysis comparing the incremental societal costs and
effects (in lives saved, life-years saved, and quality-of-life-years saved) of the
cervical cancer intervention implemented in physicians' offices.

The long-term goal of this project therefore is to reduce cervical cancer risks among ethnic
and racial minorities, by influencing the screening behaviors of their primary care
physicians.


Inclusion Criteria:



- Charts of female patients age 18-85 with at least one visit to the primary care
provider over the last two years will be reviewed

Exclusion Criteria:

- Exclusion criteria will include: diagnosis of cancer other than non-melanotic skin
cancer and removal of the uterus.

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Screening

Outcome Measure:

Number of asymptomatic female patients age 18-85 who receive or are referred for a recto-pelvic bimanual examination with the collection of the Pap smear (per ACS guidelines); collected via medical chart review

Outcome Time Frame:

12-month followup

Safety Issue:

No

Principal Investigator

Sherri Sheinfeld Gorin, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Columbia University

Authority:

United States: Institutional Review Board

Study ID:

AAAA9722

NCT ID:

NCT00629993

Start Date:

January 2004

Completion Date:

August 2010

Related Keywords:

  • Cervical Cancer
  • cervical cancer screening
  • medically underserved women
  • HPV vaccine
  • Uterine Cervical Neoplasms

Name

Location

Columbia UniversityNew York, New York  10032-3784